Safety and tolerability of eptinezumab in patients with migraine: a pooled analysis of 5 clinical trials

BACKGROUND: The humanized anti-CGRP monoclonal antibody eptinezumab has been evaluated in five large-scale clinical trials conducted in patients with migraine. This integrated analysis was conducted to evaluate the comprehensive safety and tolerability of eptinezumab in patients with migraine across...

Descripción completa

Detalles Bibliográficos
Autores principales: Smith, Timothy R., Spierings, Egilius L. H., Cady, Roger, Hirman, Joe, Schaeffler, Barbara, Shen, Vivienne, Sperling, Bjørn, Brevig, Thomas, Josiassen, Mette Krog, Brunner, Elizabeth, Honeywell, Loan, Mehta, Lahar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Milan 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8008612/
https://www.ncbi.nlm.nih.gov/pubmed/33781209
http://dx.doi.org/10.1186/s10194-021-01227-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8008612/
https://www.ncbi.nlm.nih.gov/pubmed/33781209
http://dx.doi.org/10.1186/s10194-021-01227-5

Ejemplares similares